PeterLabs Holdings Bhd
KLSE:PLABS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (0.3), the stock would be worth MYR0.14 (35% downside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.5 | MYR0.22 |
0%
|
| 3-Year Average | 0.3 | MYR0.14 |
-35%
|
| 5-Year Average | 0.3 | MYR0.14 |
-33%
|
| Industry Average | 1.9 | MYR0.89 |
+316%
|
| Country Average | 1.7 | MYR0.79 |
+268%
|
Forward P/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| MY |
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
59.2m MYR | 0.5 | 378.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
835.2B USD | 12.8 | 40.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.8B USD | 5.7 | 26 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.2 | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP | 4.9 | 28 | |
| CH |
|
Novartis AG
SIX:NOVN
|
223.1B CHF | 4.8 | 19.5 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
276.9B USD | 4.3 | 15.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.8 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.5B USD | 2.5 | 19.8 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.2B USD | 2.5 | 16.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.9 |
| Median | 1.7 |
| 70th Percentile | 3 |
| Max | 5 877.6 |
Other Multiples
PeterLabs Holdings Bhd
Glance View
PeterLabs Holdings Bhd.is an investment company, which engages in the manufacture, distribution and trading of animal health and nutrition products. The company is headquartered in Nilai, Negeri Sembilan. The company went IPO on 2011-07-26. The firm is engaged in the manufacturing, distribution and trading of animal health and nutrition products. Its segments include Manufacturing and Trading. The Manufacturing segment is engaged in the manufacturing of animal health and nutrition products. The Trading segment is engaged in the trading and distribution of animal health and nutrition products. Its products include biosecurity and disinfectant, compound feed supplement, feed additives, nutritional premix, pharmaceutical and water-soluble supplement. The firm provides technical information exchange with its customer’s supervisors, technicians and in-house veterinarians, livestock information sharing, post-mortem on diseased animals, blood sampling of diseased animals for testing and individualize latest technologies in the manufacture of feed additives for feed and farming industry.
